GigaGen is a biopharmaceutical company driven by the desire to improve the outcomes for patients with severe disease. It is our mission to discover and develop novel antibody therapies that seamlessly integrate into the body’s natural immune system.

Our science captures the genetic make-up of the entire human immune repertoire to identify and replicate naturally occurring antibodies for the purpose of developing novel human mono- and polyclonal antibody therapeutics.

Therapies derived from natural immune repertoires mimic the body’s natural immune system – they can be more effective, can have fewer side effects, and can have faster development timelines than those developed from traditional methods.

GigaGen is a pre-clinical start-up based in the San Francisco Bay Area. Our team is composed of innovative professionals with a proven track record of converting ground-breaking science into life-changing medicine.